Mosaic RBD Nanoparticles Protect against Challenge by Diverse Sarbecoviruses in Animal Models

Investigators designed mosaic nanoparticles presenting randomly-arranged sarbecovirus spike receptor-binding domains (RBDs) to elicit antibodies against epitopes that were conserved and relatively occluded, rather than variable, immunodominant, and exposed.